Twinbeech Capital LP Ab Cellera Biologics Inc. Transaction History

Twinbeech Capital LP

  • $4.99 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$5.66 - $7.59 $692,744 - $928,962
122,393 New
122,393 $790,000
Q4 2022

Feb 14, 2023
BUY
$9.48 - $14.52 $1.87 Million - $2.87 Million
197,644 Added 60.54%
524,095 $5.31 Million
Q3 2022

Nov 14, 2022
BUY
$9.2 - $13.68 $3 Million - $4.47 Million
326,451 New
326,451 $3.23 Million

Others Institutions Holding ABCL

# of Institutions
154
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email